BioSyent to Present at the LD 500 Virtual Conference
24 août 2020 16h30 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 24, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) today announced that it will be presenting at the LD 500 investor conference on...
BioSyent Schedules Q2 and H1 2020 Earnings Release for August 26, 2020
17 août 2020 08h30 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 17, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30,...
BioSyent Announces the Availability of Tibella® (tibolone) in Canada
29 juil. 2020 16h01 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, July 29, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) today announced the Canadian launch and product availability of Tibella® (tibolone)...
BIOSYENT ANNOUNCES GRANT OF RESTRICTED SHARE UNITS
31 mars 2020 19h41 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 31, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved today a grant of 129,125...
BioSyent Announces Renewal of Normal Course Issuer Bid
11 déc. 2019 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Dec. 11, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the...
BioSyent Signs Exclusive Agreement for Pain Management Products
25 nov. 2019 17h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 25, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive License...
BioSyent Releases Results for Third Quarter and First Nine Months of 2019
20 nov. 2019 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 20, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and nine months ended September...
BioSyent Schedules Q3 and YTD 2019 Earnings Release for November 20, 2019
12 nov. 2019 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 12, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended...
BioSyent Named to the Growth 500 Ranking of Canada's Fastest-Growing Companies for Seventh Consecutive Year
12 sept. 2019 09h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Sept. 12, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it has been named to the 31st annual Growth 500 ranking of Canada’s...
BioSyent to Present at Raymond James Life Sciences and MedTech Conference
17 juin 2019 15h19 HE
|
BioSyent Inc.
TORONTO, June 17, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that Mr. René Goehrum, President and CEO of BioSyent, will be presenting at the 2019...